AACR 2022 | Booth #2210

April 8-13, 2022

Advancing cancer and immunotherapy research with immunosequencing

Register to attend AACR

The American Association for Cancer Research (AACR) Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy.

Adaptive is excited to be hosting a special symposium during the event, where we will be highlighting exciting research taking place across the cancer research landscape and how immune repertoire profiling with the immunoSEQ Technology is uniquely suited to answer questions related to immuno-oncology. If you are attending AACR in-person, we hope you’ll stop by booth #2210 and connect.

Exhibitor Spotlight Theater

Utilizing immunosequencing to study oncology targets and therapies

Monday, April 11 | 12:30-1:30pm
Theater B, Exhibit Hall, Ernest N. Morial Convention Center

Join us to learn about:

  • The principles behind the immunoSEQ Technology and an overview of the immunoSEQ HLA Classifier
  • Immuno-oncology target identification using coupled immunogenomics
  • Transgenic T-cell receptor adoptive cell therapies: addressing epigenetic suppression & optimizing therapies with immunosequencing


Patrick Raber, Ph.D.

Director, Business Development

Adaptive Biotechnologies

Kellie N. Smith, Ph.D.

Assistant Professor of Oncology

Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine

Theodore Scott Nowicki, MD, Ph.D.

Assistant Professor-in-Residence, Pediatric Hematology/Oncology

University of California Los Angeles

immunoSEQ Product Resources

Learn more about immunoSEQ Assay by downloading these helpful resources:

Contact us

Have Questions? Need to speak with someone?

Request information
Covid Icon Covid Icon
COVID-19 Applications

Learn how immunoSEQ® T-MAP™ COVID can help uncover the T-cell immune response in COVID-19.

Learn More
Library Icon Email Icon

Access technical documents for getting started with the immunoSEQ® Service product, grant writing support, and FAQs.

Learn More